Pay in 4 interest-free payments of $7.03 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
And its not about swapping in diet versions or making compromises
doi: 10.2337/db22-727-P 88 ChavdaVPAjabiyaJTeliDBojarskaJApostolopoulosV
Regular follow-up with your healthcare team allows for ongoing assessment and adjustment of your treatment plan
Liraglutide is the active ingredient in two well-known brand-name GLP-1 injections: Victoza, prescribed for type 2 diabetes (typically at doses of 1.2 mg to 1.8 mg per day), and Saxenda, used for weight loss (at a higher daily dose of 3 mg)
Semaglutide activates GLP-1 receptors concentrated in the gut, pancreas, and brain
Important safety information, in line with the UK SmPC and MHRA guidance: Pancreatitis: semaglutide has been associated with a small increased risk of pancreatitis
